Roche’s virtual event at the 2022 ASCO Annual Meeting focusing on the oncology pipeline
Oncology late-stage portfolio update
Key Data at ASCO 2022
- Glofitamab pivotal Ph1b data in 3L+DLBCL
- Polivy Asian sub-population data from Ph3 POLARIX in 1L DLBCL
Oncology early R&D update
Elena Bernedo-Arzac, SVP, Oncology Therapeutic Area Head
Ginna Laporte, MD VP, Global Head Lymphoma/CLL Clinical Development
Johanna Bendell, M.D., Head of Roche Pharma Research and Early Development (pRED) Oncology
Andy Chan, M.D., Ph.D. Senior Vice President, Research Biology, Genentech Research & Early Development (gRED)

Please register to access the replay*

*Privacy notice

Past IR Events
View more Events

Roche has hosted a virtual event on Monday, 6 June 2022.


Discover more